Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1979 Nov 17;2(6200):1257–1259. doi: 10.1136/bmj.2.6200.1257

Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes.

S Madsbad, K G Alberti, C Binder, J M Burrin, O K Faber, T Krarup, L Regeur
PMCID: PMC1596922  PMID: 117878

Abstract

The role of preserved beta-cell function in preventing ketoacidosis in type I insulin-dependent diabetes was assessed in eight patients with and seven patients without residual beta-cell function as determined from C-peptide concentrations. After 12 hours of insulin fatty-acid, and glycerol concentrations were all significantly higher in patients without beta-cell function than in those with residual secretion. Mean blood glucose concentrations reached 17.2 +/- SE of mean 1.3 mmol/l (310 +/- 23 mg/100 ml) in the first group compared with 8.8 +/- 1.4 mmol/l (159 +/- 25 mg/100 ml) in the second (P less than 0.01), while 3-hydroxybutyrate concentrations rose to 5.5 +/- mmol/l (57 +/- 5 mg/100 ml) and 1.4 +/- 0.3 mmol/l (15 +/- 3 mg/100 ml) in the two groups respectively (P less than 0.01). Individual mean C-peptide concentrations showed a significant inverse correlation with the final blood glucose values (r = -0.91; P less than 0.02). These findings strongly suggest that even minimal residual insulin secretion is important for metabolic wellbeing in diabetes and may prevent the development of severe ketoacidosis when insulin delivery is inadequate.

Full text

PDF
1257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti K. G. Role of glucagon and other hormones in development of diabetic ketoacidosis. Lancet. 1975 Jun 14;1(7920):1307–1311. doi: 10.1016/s0140-6736(75)92315-6. [DOI] [PubMed] [Google Scholar]
  2. Barnes A. J., Bloom S. R., Goerge K., Alberti G. M., Smythe P., Alford F. P., Chisholm D. J. Ketoacidosis in pancreatectomized man. N Engl J Med. 1977 Jun 2;296(22):1250–1253. doi: 10.1056/NEJM197706022962202. [DOI] [PubMed] [Google Scholar]
  3. Faber O. K., Markussen J., Naithani V. K., Binder C. Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. Hoppe Seylers Z Physiol Chem. 1976 Jun;357(6):751–757. doi: 10.1515/bchm2.1976.357.1.751. [DOI] [PubMed] [Google Scholar]
  4. Gerich J. E., Lorenzi M., Bier D. M., Schneider V., Tsalikian E., Karam J. H., Forsham P. H. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med. 1975 May 8;292(19):985–989. doi: 10.1056/NEJM197505082921901. [DOI] [PubMed] [Google Scholar]
  5. Ho R. J., Meng H. C. A simple and ultrasensitive method for determination of free fatty acid by radiochemical assay. Anal Biochem. 1969 Oct 1;31(1):426–436. doi: 10.1016/0003-2697(69)90284-x. [DOI] [PubMed] [Google Scholar]
  6. Ludvigsson J., Heding L. G. C-peptide in children with juvenile diabetes. A preliminary report. Diabetologia. 1976 Dec;12(6):627–630. doi: 10.1007/BF01220642. [DOI] [PubMed] [Google Scholar]
  7. Madsbad S., Faber O. K., Binder C., McNair P., Christiansen C., Transbøl I. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes. 1978;27 (Suppl 1):262–264. doi: 10.2337/diab.27.1.s262. [DOI] [PubMed] [Google Scholar]
  8. Shima K., Tanaka R., Morishita S., Tarui S., Kumahara Y. Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve. Diabetes. 1977 Aug;26(8):717–725. doi: 10.2337/diab.26.8.717. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES